A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab
1443-0003
Phase 1 other active
Quick answer
A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab for non-small cell lung cancer or, melanoma, head and neck squamous cell carcinoma is a Phase 1 program (other) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- non-small cell lung cancer or, melanoma, head and neck squamous cell carcinoma
- Phase
- Phase 1
- Modality
- other
- Status
- active